HCA Healthcare, Inc. $HCA Shares Purchased by Shell Asset Management Co.

Key Points

• Shell Asset Management Co. increased its holdings in HCA Healthcare by 39.6%, owning a total of 14,382 shares valued at approximately $5.51 million.
• During the first quarter, several institutional investors significantly increased their stakes in HCA Healthcare, including Nuveen LLC and Pacer Advisors Inc., reflecting a growing interest in the company's stock.
• HCA Healthcare reported a quarterly earnings per share of $6.84, exceeding expectations, along with a revenue increase of 6.4% year-over-year, and set guidance for FY 2025 earnings between 25.500-27.000 EPS.

Shell Asset Management Co. increased its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 39.6% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 14,382 shares of the company's stock after acquiring an additional 4,081 shares during the period. Shell Asset Management Co.'s holdings in HCA Healthcare were worth $5,510,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Nuveen LLC purchased a new position in HCA Healthcare in the 1st quarter worth approximately $569,217,000. Pacer Advisors Inc. grew its stake in shares of HCA Healthcare by 6,237.9% in the first quarter. Pacer Advisors Inc. now owns 1,350,933 shares of the company's stock worth $466,815,000 after acquiring an additional 1,329,618 shares in the last quarter. Price T Rowe Associates Inc. MD grew its stake in shares of HCA Healthcare by 83.4% in the first quarter. Price T Rowe Associates Inc. MD now owns 2,399,372 shares of the company's stock worth $829,104,000 after acquiring an additional 1,091,416 shares in the last quarter. Goldman Sachs Group Inc. grew its stake in shares of HCA Healthcare by 49.1% in the first quarter. Goldman Sachs Group Inc. now owns 1,781,459 shares of the company's stock worth $615,583,000 after acquiring an additional 587,036 shares in the last quarter. Finally, Abdiel Capital Advisors LP acquired a new position in shares of HCA Healthcare in the first quarter worth $164,835,000. 62.73% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

HCA has been the subject of a number of analyst reports. Morgan Stanley lowered their target price on shares of HCA Healthcare from $410.00 to $400.00 and set an "equal weight" rating for the company in a research note on Monday, July 28th. Bank of America upped their target price on shares of HCA Healthcare from $375.00 to $410.00 and gave the company a "neutral" rating in a report on Wednesday, September 10th. Robert W. Baird upped their target price on shares of HCA Healthcare from $380.00 to $423.00 and gave the company a "neutral" rating in a report on Thursday, August 14th. Wells Fargo & Company dropped their price target on shares of HCA Healthcare from $385.00 to $375.00 and set an "equal weight" rating on the stock in a research note on Thursday, August 14th. Finally, Wall Street Zen raised shares of HCA Healthcare from a "hold" rating to a "buy" rating in a report on Saturday, July 5th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and nine have issued a Hold rating to the company's stock. Based on data from MarketBeat, HCA Healthcare presently has an average rating of "Moderate Buy" and a consensus target price of $407.75.

Insider Transactions at HCA Healthcare

In related news, EVP Michael S. Cuffe sold 3,836 shares of HCA Healthcare stock in a transaction on Monday, September 8th. The shares were sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the sale, the executive vice president owned 31,503 shares of the company's stock, valued at $13,194,716.52. The trade was a 10.85% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. 1.30% of the stock is owned by company insiders.

HCA Healthcare Stock Up 1.0%

Shares of HCA opened at $433.83 on Tuesday. The firm has a market cap of $101.51 billion, a PE ratio of 18.24, a price-to-earnings-growth ratio of 1.35 and a beta of 1.40. The company's fifty day moving average is $399.40 and its two-hundred day moving average is $373.65. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $435.03.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings results on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, beating analysts' consensus estimates of $6.20 by $0.64. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The company had revenue of $18.61 billion for the quarter, compared to analyst estimates of $18.49 billion. During the same quarter last year, the business earned $5.50 EPS. HCA Healthcare's revenue for the quarter was up 6.4% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. As a group, equities research analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th were paid a dividend of $0.72 per share. The ex-dividend date of this dividend was Tuesday, September 16th. This represents a $2.88 annualized dividend and a yield of 0.7%. HCA Healthcare's payout ratio is 12.11%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.